Endometriose und Karzinogenese

In: Gynäkologische Endokrinologie · 2026 · vol. 24(2) , pp. 112–117 · doi:10.1007/s10304-026-00685-x · W7154308614
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-08

Endometriosis, characterized by infertility and pain, involves a 2-4x increased risk of ovarian cancer, with molecular pathology recognizing suspected but speculative somatic gene alterations potentially leading to malignant transformation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

The paper discusses endometriosis as a complex disease characterized by infertility and chronic pain, noting a 2–4-fold increased risk of developing ovarian cancer. It reviews advances in molecular pathology, describing the recognition of somatic gene alterations that could potentially link endometriosis with malignant transformation, while emphasizing that genomic alterations remain largely speculative at present. A key caveat explicitly stated is that the evidence for a direct causal genomic pathway is not yet established. This paper is centrally about endometriosis — focusing on how endometriosis may relate to carcinogenesis and ovarian cancer risk.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 7,466 characters · extracted from oa-doi-fallback · click to expand
Zusammenfassung Endometriose ist eine Erkrankung hoch komplexer Pathologie. Charakteristisch sind Infertilität und chronische Schmerzzustände. Darüber hinaus besteht ein 2‑ bis 4‑fach erhöhtes Risiko zur Entwicklung eines Ovarialkarzinoms. Die Molekularpathologie kennt inzwischen somatische Gen-Alterationen, die potenziell zu Endometriose und auch zu einer malignen Transformation führen können. Genomische Alterationen liegen nahe, sind aber zum jetzigen Zeitpunkt noch eher spekulativ. Abstract Endometriosis is a disease with a highly complex pathology. Characteristic features are infertility, chronic pain and a 2–4-fold increased risk of ovarian cancer. The molecular pathology now recognizes somatic gene alterations that can potentially lead to endometriosis and also to a malignant transformation. Genomic alterations are suspected but currently are still speculative. Similar content being viewed by others Literatur Kvaskoff M, Mu F, Terry KL, Harris HR, Poole EM, Farland L, Missmer SA. Endometriosis: a high-risk population for major chronic diseases? Hum ReprodUpdat2015 Jul-Aug;21(4):500–16. https://doi.org/10.1093/humupd/dmv013. Epub 2015 Mar 11. PMID: 25765863; PMCID: PMC44630001 Bulun SE. Endometriosis. N Engl J Med. 2009 Jan 15;360(3):268–79. https://doi.org/10.1056/NEJMra0804690. PMID: 19144942. .Brosens I, Pijnenborg R, Benagiano G. Defective myometrial spiral artery remodelling as a cause of major obstetrical syndromes in endometriosis and adenomyosis. Placenta. 2013 Feb;34(2):100–5. https://doi.org/10.1016/j.placenta.2012.11.017. Epub 2012 Dec 8. PMID: 23232321. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J, Bulun SE. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007 Oct;77(4):681–7. https://doi.org/10.1095/biolreprod.107.061804. Epub 2007 Jul 11. PMID: 17625110. Cheng YH, Yin P, Xue Q, Yilmaz B, Dawson MI, Bulun SE. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. J Clin Endocrinol Metab. 2008 May;93(5):1915–23. https://doi.org/10.1210/jc.2007-1536. Epub 2008 Feb 12. PMID: 18270252; PMCID: PMC2386682. Sanchez AM, Viganò P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014 Mar-Apr;20(2):217–30. https://doi.org/10.1093/humupd/dmt053. Epub 2013 Oct 14. PMID: 24129684. Brinton LA, Gridley G, Persson I et al. (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176: 572–579 Melin A, Sparén P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006 May;21(5):1237–42. https://doi.org/10.1093/humrep/dei462. Epub 2006 Jan 23. PMID: 16431901. Peirce CL, Templeman C, Rossing MA. On behalf of the Ovarian cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13:385–394. Matalliotakis I, Mahutte NG, Koukoura O, Arici A. Endometriosis-associated stage IA clear cell ovarian carcinoma in a woman with IVF-ET treatments in the Yale series. Arch Gynecol Obstet 2006;274:184–6. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K‑ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2005 Jan;11(1):63–70. https://doi.org/10.1038/nm1173. Epub 2004 Dec 26. PMID: 15619626. Suda K, Nakaoka H, Yoshihara K, Ishiguro T, Tamura R, Mori Y, Yamawaki K, Adachi S, Takahashi T, Kase Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K‑ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2005 Jan;11(1):63–70. https://doi.org/10.1038/nm1173. Epub 2004 Dec 26. PMID: 15619626. Suda K, Nakaoka H, Yoshihara K, Ishiguro T, Tamura R, Mori Y, Yamawaki K, Adachi S, Takahashi T, Kase H, Tanaka K, Yamamoto T, Motoyama T, Inoue I, Enomoto T. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium. Cell Rep. 2018 Aug 14;24(7):1777–1789. https://doi.org/10.1016/j.celrep.2018.07.037. PMID: 30110635. H, Tanaka K, Yamamoto T, Motoyama T, Inoue I, Enomoto T. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium. Cell Rep. 2018 Aug 14;24(7):1777–1789. https://doi.org/10.1016/j.celrep.2018.07.037. PMID: 30110635 Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, Ho J, Wu RC, Lac V, Ogawa H, Tessier-Cloutier B, Alhassan R, Wang A, Wang Y, Cohen JD, Wong F, Hasanovic A, Orr N, Zhang M, Popoli M, McMahon W, Wood LD, Mattox A, Allaire C, Segars J, Williams C, Tomasetti C, Boyd N, Kinzler KW, Gilks CB, Diaz L, Wang TL, Vogelstein B, Yong PJ, Huntsman DG, Shih IM. Cancer-Associated Mutations in Endometriosis without Cancer. N Engl J Med. 2017 May 11;376(19):1835-1848. https://doi.org/10.1056/NEJMoa1614814. PMID: 28489996; PMCID: PMC5555376. Ulrich U, Jagdhuhn A, Noack F, Schmidt D, Wardelmann E. Charakterisierung Endometriose-assoziierter Malignome: Projekt der Stiftung Endometrioseforschung und der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO). GebFra. 10.11.2020. Rommel, B., Holzmann, C. und Bullerdiek, J (2016) Malignant mesenchymal tumors of the uterus – time to advocate a genetic classification. Expert Review of Anticancer Therapy 16, 1155–1166. https://doi.org/10.1080/14737140.2016.1233817 Lee, S. H., Harold, D., Nyholt, D.R., ANZGene Consortium (2013) Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer’s disease, multiple sclerosis and endometriosis. Hum. Mol. Genet. 22, 832–841. https://doi.org/10.1093/hmg/dds491 Sapkota, Y., Steinthorsdottir, V., Morris, A.P. et al. (2017) Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat. Commun. 8, 15539. https://doi.org/10.1038/ncomms15539 Förderung Keine. Author information Authors and Affiliations Corresponding author Ethics declarations Interessenkonflikt W. Küpker, R.E. Felberbaum, J. Bullerdiek, J. Aizpurua, S. Mechsner, U. Ulrich und K. Diedrich geben an, dass kein Interessenkonflikt besteht. Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Additional information Redaktion Ricardo Felberbaum, Kempten Katharina Hancke, Ulm Wolfgang Janni, Ulm Wolfgang Küpker, Baden-Baden Hinweis des Verlags Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral. QR-Code scannen & Beitrag online lesen Rights and permissions About this article Cite this article Küpker, W., Felberbaum, R.E., Bullerdiek, J. et al. Endometriose und Karzinogenese. Gynäkologische Endokrinologie 24, 112–117 (2026). https://doi.org/10.1007/s10304-026-00685-x Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s10304-026-00685-x

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Source provenance

openalex
last seen: 2026-07-14T06:01:30.382735+00:00
unpaywall
last seen: 2026-09-02T07:26:43.000666+00:00
License: CC0 · commercial use OK